Table 2.
Association of human leukocyte antigen (HLA) haplotypes and female patients with multiple sclerosis (MS) in Khuzestan, Iran
| HLA haplotypes |
Positive haplotype
|
Total
|
P | ||
|---|---|---|---|---|---|
| Patients [n (%)] | Controls [n (%)] | Patients | Controls | ||
| DRB1*1501+-DRB5*01+ | 19 (12.02) | 11 (18.03) | 158 | 61 | 0.246 |
| DRB1*1501--DRB5*01- | 62 (41.33) | 34 (52.30) | 150 | 65 | 0.137 |
| DRB1*1501+-DRB5*01- | 43 (27.21) | 13 (20.00) | 158 | 65 | 0.259 |
| DRB1*1501--DRB5*01+ | 23 (16.19) | 6 (6.12) | 142 | 98 | 0.019* |
HLA: Human leukocyte antigen
*
Significant P-values; statistical significance was at P < 0.050.